Systemic sclerosis and cryoglobulinemia: Our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature

Autoimmunity Reviews

Volumn 12, Issue 11, 2013, Pages 1058-1063

  Giuggioli, Dilia ^a   Manfredi, Andreina ^a   Colaci, Michele ^a   Manzini, Carlo Umberto ^a   Antonelli, Alessandro ^b   Ferri, Clodoveo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Cryoglobulinemic vasculitis; Hepatitis C virus; Mixed cryoglobulinemia; Rituximab; Skin ulcers; Systemic sclerosis

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CENTROMERE ANTIBODY; COMPLEMENT COMPONENT C4; CRYOGLOBULIN; ILOPROST; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR; RITUXIMAB; STEROID;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ASYMPTOMATIC DISEASE; CAUSE OF DEATH; CRYOGLOBULINEMIA; CRYOGLOBULINEMIC VASCULITIS; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HEART FAILURE; HEPATITIS C; HUMAN; KNEE AMPUTATION; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MEDLINE; MICROANGIOPATHY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PLASMAPHERESIS; PREVALENCE; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SCLERODERMA; SKIN ULCER; SYSTEMIC SCLEROSIS; VASCULITIS; WOUND HEALING IMPAIRMENT;

CRYOGLOBULINEMIC VASCULITIS; CV; HCV; HEPATITIS C VIRUS; MC; MCS; MIXED CRYOGLOBULINEMIA; MIXED CRYOGLOBULINEMIA SYNDROME; RITUXIMAB; SKIN ULCERS; SSC; SYSTEMIC SCLEROSIS;

AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CRYOGLOBULINEMIA; FEMALE; HEPACIVIRUS; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SYNDROME; SYSTEMIC VASCULITIS; VASCULITIS;

EID: 84881548383     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.06.013     Document Type: Review

References (40)

1. Ferri C., Valentini G., Cozzi F., Sebastiani M., Michelassi C., La Montagna G., et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1012 Italian patients. Medicine 2002, 81:139-153.
2. Chighizola C., Shoenfeld Y., Meroni P.L. Systemic sclerosis. Introduction. Autoimmun Rev Mar 2011, 10(5):239-240. 10.1016/j.autrev.2011.02.005.
3. Derk C.T., Jimenez S.A. Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2003, 2:181-191.
4. Martin P., Teodoro W.R., Velosa A.P., de Morais J., Carrasco S., Christmann R.B., et al. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis. Autoimmun Rev Sep 2012, 11(11):827-835. [Review]. 10.1016/j.autrev.2012.02.017.
5. Kahaleh B. Vascular disease in scleroderma: mechanisms of vascular injury. Rheum Dis Clin North Am 2008, 34:57-71. 10.1016/j.rdc.2007.12.004.
6. Wigley F.M. Vascular disease in scleroderma. Clin Rev Allergy Immunol 2009, 36:150-175.
7. Cipriani P., Marrelli A., Liakouli V., Di Benedetto P., Giacomelli R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev Aug 2011, 10(10):641-646. [Review]. 10.1016/j.autrev.2011.04.016.
8. Soltész P., Kerekes G., Dér H., Szücs G., Szántó S., Kiss E., et al. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. Autoimmun Rev May 2011, 10(7):416-425. [Review]. 10.1016/j.autrev.2011.01.004.
9. Arnson Y., Amital H., Agmon-Levin N., Alon D., Sánchez-Castañón M., López-Hoyos M., et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev Jun 2011, 10(8):490-494. [Review]. 10.1016/j.autrev.2011.02.002.
10. Kao L., Weyand C. Vasculitis in systemic sclerosis. Int J Rheumatol 2010, 2010:385938. 10.1155/2010/385938.
11. Fenoglio D., Bernuzzi F., Battaglia F., Parodi A., Kalli F., Negrini S., et al. Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. Autoimmun Rev Dec 2012, 12(2):300-304. [Review]. 10.1016/j.autrev.2012.05.004.
12. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23:581-590.
13. Johnson S.R., Fransen J., Khanna D., Baron M., van den Hoogen F., Medsger T.A., et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken) 2011, 64:358-367.
14. Colaci M., Giuggioli D., Sebastiani M., Manfredi A., Vacchi C., Spagnolo P., et al. Lung cancer in scleroderma: results from an Italian Rheumatologic Centre and review of the literature. Autoimmun Rev 2013, 12:374-379. 10.1016/j.autrev.2012.06.003.
15. Rossi D., Russo A., Manna E., Binello G., Baldovino S., Sciascia S., et al. The role of nail-videocapillaroscopy in early diagnosis of scleroderma. Autoimmun Rev June 2013, 12(8):821-825. [Epub 2012 Dec 4]. 10.1016/j.autrev.2012.11.006.
16. Villalta D., Imbastaro T., Di Giovanni S., Lauriti C., Gabini M., Turi M.C., et al. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis. Autoimmun Rev Dec 2012, 12(2):114-120. [Review]. 10.1016/j.autrev.2012.07.005.
17. Giuggioli D., Manfredi A., Colaci M., Lumetti F., Ferri C. Scleroderma digital ulcers complicated by infection with fecal pathogens. Arthritis Care Res (Hoboken) 2012, 64:295-297. 10.1002/acr.20673.
18. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 2008, 16(3):25. 10.1186/1750-1172-3-25.
19. De Vita S., Soldano F., Isola M., Monti G., Gabrielli A., Tzioufas A., et al. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis 2011, 70:1183-1190.
20. Ferri C., Antonelli A., Mascia M.T., Sebastiani M., Fallahi P., Ferrari D., et al. B-cells and mixed cryoglobulinemia. Autoimmun Rev 2007, 7:114-120.
21. Visentini M., Conti V., Cristofoletti C., Lazzeri C., Marrapodi R., Russo G., et al. Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity. Autoimmun Rev Jan 2013, 12(3):430-435. 10.1016/j.autrev.2012.08.016.
22. Duarte-Rey C., Bogdanos D.P., Leung P.S., Anaya J.M., Gershwin M.E. IgM predominance in autoimmune disease: genetics and gender. Autoimmun Rev May 2012, 11(6-7):A404-A412. [Epub 2011 Dec 8. Review]. 10.1016/j.autrev.2011.12.001.
23. Antonelli A., Ferri C., Ferrari S.M., Colaci M., Fallahi P. Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev 2008, 8:18-23.
24. Pons-Estel G.J., Salerni G.E., Serrano R.M., Gomez-Puerta J.A., Plasin M.A., Aldasoro E., et al. Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature. Autoimmun Rev Sep 2011, 10(11):679-684. [Epub 2011 May 1. Review]. 10.1016/j.autrev.2011.04.028.
25. Almeida I., Faria R., Vita P., Vasconcelos C. Systemic sclerosis refractory disease: from the skin to the heart. Autoimmun Rev Sep 2011, 10(11):693-701. [Review]. 10.1016/j.autrev.2011.04.025.
26. Husson J.M., Druet P., Contet A., Fiessinger J.N., Camilleri J.P. Systemic sclerosis and cryoglobulinemia. Clin Immunol Immunopathol 1976, 6:77-82.
27. Jimenez Lopez A., Garcia Marcos M.A., Fernandez-Roldan C.C., Fuertes Martín K., Hernández Vicente I., Pastor Encinas I. CRST syndrome and mixed cryoglobulinemia. Med Clin (Barc) 1980, 74:31-33.
28. Buskila D., Langevitz P., Lee P. The frequency of cryoglobulinaemia in systemic sclerosis (scleroderma). Br J Rheumatol 1990, 29:234.
29. Ostojic P. Cryoglobulinemic vasculitis in systemic sclerosis successfully treated with mycophenolate mofetil. Rheumatol Int 2012, 28.
30. Quemeneur T., Mouthon L., Cacoub P., Meyer O., Michon-Pasturel U., Vanhille P., et al. Systemic vasculitis during the course of systemic sclerosis. Medicine (Baltimore) 2013, 92:1-9. 10.1097/MD.0b013e31827781fd.
31. Fischer A., Bull T.M., Steen V.D. Practical approach to screening for scleroderma-associated pulmonary arterial hypertension. Arthritis Care Res 2012, 64:303-310.
32. Bosello S., De Luca G., Tolusso B., Lama G., Angelucci C., Sica G., et al. B cells in systemic sclerosis: a possible target for therapy. Autoimmun Rev 2011, 10:624-630.
33. Pietrogrande M., Devita S., Zignego A., Pioltelli P., Sansonno D., Sollima S., et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 2011, 10:444-454. 10.1016/j.autrev.2011.01.008.
34. Ferri C., Cacoub P., Mazzaro C., Roccatello D., Scaini P., Sebastiani M., et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev 2011, 11:48-55. 10.1016/j.autrev.2011.07.005.
35. De Vita S., Quartuccio L., Isola M., Mazzaro C., Scaini P., Lenzi M., et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 2012, 64:843-853.
36. Visentini M., Ludovisi S., Petrarca A., Pulvirenti F., Zaramella M., Monti M., et al. A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection. Autoimmun Rev Sep 2011, 10(11):714-719. 10.1016/j.autrev.2011.04.033.
37. Daoussis D., Liossis S.N., Yiannopoulos G., Andonopoulos A.P. B-cell depletion therapy in systemic sclerosis: experimental rationale and update on clinical evidence. Int J Rheumatol 2011, 2011:214013.
38. García-Carrasco M., Jiménez-Hernández M., Escárcega R.O., Mendoza-Pinto C., Galarza-Maldonado C., Sandoval-Cruz M., et al. Use of rituximab in patients with systemic lupus erythematosus: an update. Autoimmun Rev 2009, 8:343-348. 10.1016/j.autrev.2008.11.006.
39. Kattah A.G., Fervenza F.C., Roccatello D. Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases. Autoimmun Rev Jun 2013, 12(8):854-859. 10.1016/j.autrev.2012.09.002.
40. Baldini C., Mosca M., Della Rossa A., Pepe P., Notarstefano C., Ferro F., et al. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Clin Exp Rheumatol 2013, 31:272-280.